Molbio Diagnostics Shares In Focus As Motilal Oswal Initiates Coverage; Check Target Price. Motilal Oswal believes Molbio's successful diversification beyond TB, stronger international adoption and improving cash conversion could support a re-rating, while dependence on government orders and elevated working capital remain key risks.